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The introduction of high-throughput measurement techniques has transformed modern 
biology, where the phrase “high-throughput” should be seen in the light of the number of 
variables measured rather than the number of samples: that is, we have many data about 
few objects. Finding differences between two groups of objects (patients and controls, 
different varieties of fruits, different food products, …) has become a very important area of 
research. The classical statistical tests in most cases suffer from many false positives from 
multiple testing, and correcting for this often leads to low power. Moreover, it is unclear what 
threshold to choose: in many cases the level of alpha is being adjusted until the number of 
“significant” variables seems more or less right (for whatever reason: follow-up experiments 
typically are more time-consuming and one may be forced to settle for the best twenty or 
thirty variables). 
 
The R package BioMark addresses both the problem of what threshold to choose, and how 
to select relevant variables by providing Higher Criticism thresholding (Donoho and Jin, 
2008) and Stability Selection (Meinshausen and Buehlmann, 2010), respectively. The HC 
approach is a kind of second-level significance testing: it assesses the distribution of p 
values from a primary test and compares that to the expected uniform distribution. Assuming 
that real differences are rare and weak, the method then suggests an appropriate cutoff 
point, based on the data at hand. Stability selection works by repeatedly subsampling the 
data, and only considering those variables as putative biomarkers that consistently show up 
as important.   
 
We have adapted both Higher Criticism and Stability Selection for use with omics data, and 
provide an easily accessible implementation in our BioMark package, available from CRAN 
(http://cran.r-project.org). The Higher Criticism approach is extended to also work with 
methods typically employed in metabolomics and proteomics, such as PLSDA, 
PCLDA and the VIP measure (Wehrens and Franceschi, 2012). Since no null 
distribution can be defined beforehand, it is derived using label permutations, and 
the results show excellent performance for experimental spike-in data (also included 
in the BioMark package). The same multivariate methods have been combined with 
stability selection (Wehrens et al., 2011) and again show very good results, testifying 
of the robustness of the stability selection paradigm. 
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